- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
10x Genomics Secures Distributors for the Asia-Pacific Region
PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc., today announced that it has entered into distribution agreements with MDxK, Inc., Millennium Science Pty Ltd, Research Instruments Pte Ltd, and Star Research Technology Ltd., for the promotion, sales, and support of 10x’s ChromiumTM System and associated products to address long range and single cell genomic applications in Asia and …
PLEASANTON, Calif.–(BUSINESS WIRE)–10x Genomics, Inc., today announced that it has entered into
distribution agreements with MDxK, Inc., Millennium Science Pty Ltd,
Research Instruments Pte Ltd, and Star Research Technology Ltd., for the
promotion, sales, and support of 10x’s ChromiumTM System and
associated products to address long range and single cell genomic
applications in Asia and Pacific Rim markets (APAC).
The distribution agreements cover South Korea (MDxK), Australia and New
Zealand (Millennium Science), Southeast Asia (Research Instruments), and
China (Star Research Technology).
“The Asia-Pacific region is experiencing significant growth across all
areas of genomics spurring demand for solutions that provide full
sequence information and genomic analysis at single cell resolution,”
said Dr. Serge Saxonov, 10x’s Chief Executive Officer, “we are thrilled
to welcome Millennium Science, MDxK, Research Instruments, and Star
Research Technology, each premier life science instrumentation
distributors in their respective regions, as key partners to 10x. These
partnerships represent an important step in the global commercial
expansion of 10x, and working together, we will be able to better serve
our customers’ needs in the Asia-Pacific region.”
10x’s microfluidics-based molecular barcoding solutions, built on the
proprietary GemCode™ Technology, provide researchers critical long-range
sequence information through existing sequencing workflows. The Chromium
Genome and Exome Solutions together include phasing, structural variant
analysis, de novo genome assembly, and remapping of difficult
regions of the genome. In addition, 10x’s recently introduced Chromium
Single Cell Solution allows for rapid and comprehensive analysis of
dynamic transcription events from large numbers of individual cells.
“We are excited to be working with 10x to bring the Chromium System to
market and introduce important new dimensions to our customers’
research”, said Steven Qiu, Chief Executive Officer of Star Research
Technology. “10x Genomics is recognized for delivering critical enabling
applications, including long-range sequence information and
high-throughput single cell analysis. This partnership will enable our
NGS customers to access 10x’s linked-read sequencing products and
significant new capabilities that will power further advances in single
cell biology and genomic research.”
10x Genomics distributor information can be found at 10xGenomics.com/distributors.
About 10x Genomics
10x Genomics is changing the definition of sequencing by providing an
innovative genomics platform that dramatically upgrades the capabilities
of existing sequencing technologies. This is achieved through a
combination of new microfluidic science, chemistry and bioinformatics.
By implementing GemCodeTM Technology within the Chromium
System, researchers can now, for the first time, find new structural
variants, haplotypes, and other valuable genomic information with
comprehensive workflows for Single Cell, Genome and Exome applications
that incorporate their pre-existing sequencing technologies.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.